Biomarkers for anti-nogo-a antibody treatment in spinal cord...

G - Physics – 01 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

G01N 33/50 (2006.01)

Patent

CA 2627966

This disclosure of this invention confirms, at the level of gene expression, the injured spinal cord and motor cortex as the primary sites of action of the anti-Nogo-A antibody treatment applied intra thecally. The disclosure further provides methods for monitoring the response of a subject to a medicament comprising an anti-Nogo-A antibody by assessing the expression of at least one gene selected from Cadherin 2, 8, 11 or 22; Ephrin A3 or B2,- Eph receptor A3 of A4; Semaphorin 4A, 4D, 4F, 6A or 6B; Plexin B2; Capping protein (actin filament, gelsolin-like); Casein kinase 1 delta; Centractin; Gelsolin; Microtubule-associated protein tau; Neurofilament 68; Myocilin; Olfactomedin 1 or 3; Interferon gamma; Rho-GDP-dissociation inhibitor 1; Dihydropyrimidinase related protein (CRMP) 1, 2 or 5; Synuclein; Amyloid beta (A4) PP-binding A1; Amyloid beta (A4) precursor-like protein 1 or 2; Prostaglandin E synthase; Benzodiazepine receptor or Biglycan.

La présente invention confirme, au niveau de l'expression génique, que la moelle épinière lésée et le cortex moteur sont les sites principaux d'action du traitement aux anticorps anti-Nogo-A appliqué par voie intrathécale. La description propose en outre des procédés pour prévoir la réponse d'un sujet à un médicament comprenant un anticorps anti-Nogo-A.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Biomarkers for anti-nogo-a antibody treatment in spinal cord... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Biomarkers for anti-nogo-a antibody treatment in spinal cord..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Biomarkers for anti-nogo-a antibody treatment in spinal cord... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2087862

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.